{"id":11252,"date":"2019-06-18T00:00:00","date_gmt":"2019-06-18T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/1970\/01\/01\/congres-annuel-2019-de-l-european-hematology-association\/"},"modified":"2025-08-19T08:28:21","modified_gmt":"2025-08-19T13:28:21","slug":"congres-annuel-2019-de-l-european-hematology-association","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/","title":{"rendered":"CONGR\u00c8S ANNUEL 2019 DE L&rsquo; EUROPEAN HEMATOLOGY ASSOCIATION"},"content":{"rendered":"<p>Nous revenons tout juste du congr\u00e8s annuel 2019 de l\u2019EHA (European Hematology Association&nbsp;), au cours duquel la professeure Maria-Victoria Mateos (Universit\u00e9 de Salamanque, Espagne) a discut\u00e9 d\u2019\u00e9tudes remarquables sur le my\u00e9lome multiple.Elle a pr\u00e9sent\u00e9 les r\u00e9sultats prometteurs du premier volet de l\u2019\u00e9tude CASSIOPEIA portant sur l\u2019ajout du daratumumab \u00e0 la combinaison bort\u00e9zomib-thalidomide-dexam\u00e9thasone (D-VTd) comparativement \u00e0 la combinaison VTd chez les patients atteints d\u2019un my\u00e9lome multiple nouvellement diagnostiqu\u00e9 qui sont admissibles \u00e0 une greffe. Elle a \u00e9galement discut\u00e9 de certaines des conclusions importantes des \u00e9tudes FORTE et GEM-CESAR, et a termin\u00e9 sa pr\u00e9sentation en parlant de l\u2019\u00e9tude ELOQUENT-3 dans le cas de rechutes et de l\u2019\u00e9tude COLUMBA.&nbsp;<\/p>\n<p><a href=\"https:\/\/ecancer.org\/video\/8027\/myeloma-highlights-from-eha-2019.php\" target=\"_blank\" rel=\"noopener\">Visionnez la vid\u00e9o<\/a> (en anglais)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nous revenons tout juste du congr\u00e8s annuel 2019 de l\u2019EHA (European Hematology Association&nbsp;), au cours duquel la professeure Maria-Victoria Mateos (Universit\u00e9 de Salamanque, Espagne) a discut\u00e9 d\u2019\u00e9tudes remarquables sur le my\u00e9lome multiple.Elle a pr\u00e9sent\u00e9 les r\u00e9sultats prometteurs du premier volet de l\u2019\u00e9tude CASSIOPEIA portant sur l\u2019ajout du daratumumab \u00e0 la combinaison bort\u00e9zomib-thalidomide-dexam\u00e9thasone (D-VTd) comparativement \u00e0 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[50,50,52,52],"tags":[],"class_list":["post-11252","post","type-post","status-publish","format-standard","hentry","category-news-events","category-whats-new-at-myeloma-canada"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Nous revenons tout juste du congr\u00e8s annuel 2019 de l\u2019EHA (European Hematology Association ), au cours duquel la professeure Maria-Victoria Mateos (Universit\u00e9 de Salamanque, Espagne) a discut\u00e9 d\u2019\u00e9tudes remarquables sur le my\u00e9lome multiple.Elle a pr\u00e9sent\u00e9 les r\u00e9sultats prometteurs du premier volet de l\u2019\u00e9tude CASSIOPEIA portant sur l\u2019ajout du daratumumab \u00e0 la combinaison bort\u00e9zomib-thalidomide-dexam\u00e9thasone (D-VTd) comparativement \u00e0\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"lemieuxbedard\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"My\u00e9lome Canada |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"CONGR\u00c8S ANNUEL 2019 DE L\u2019 EUROPEAN HEMATOLOGY ASSOCIATION | My\u00e9lome Canada\" \/>\n\t\t<meta property=\"og:description\" content=\"Nous revenons tout juste du congr\u00e8s annuel 2019 de l\u2019EHA (European Hematology Association ), au cours duquel la professeure Maria-Victoria Mateos (Universit\u00e9 de Salamanque, Espagne) a discut\u00e9 d\u2019\u00e9tudes remarquables sur le my\u00e9lome multiple.Elle a pr\u00e9sent\u00e9 les r\u00e9sultats prometteurs du premier volet de l\u2019\u00e9tude CASSIOPEIA portant sur l\u2019ajout du daratumumab \u00e0 la combinaison bort\u00e9zomib-thalidomide-dexam\u00e9thasone (D-VTd) comparativement \u00e0\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2019-06-18T05:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-08-19T13:28:21+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"CONGR\u00c8S ANNUEL 2019 DE L\u2019 EUROPEAN HEMATOLOGY ASSOCIATION | My\u00e9lome Canada\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Nous revenons tout juste du congr\u00e8s annuel 2019 de l\u2019EHA (European Hematology Association ), au cours duquel la professeure Maria-Victoria Mateos (Universit\u00e9 de Salamanque, Espagne) a discut\u00e9 d\u2019\u00e9tudes remarquables sur le my\u00e9lome multiple.Elle a pr\u00e9sent\u00e9 les r\u00e9sultats prometteurs du premier volet de l\u2019\u00e9tude CASSIOPEIA portant sur l\u2019ajout du daratumumab \u00e0 la combinaison bort\u00e9zomib-thalidomide-dexam\u00e9thasone (D-VTd) comparativement \u00e0\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/#blogposting\",\"name\":\"CONGR\\u00c8S ANNUEL 2019 DE L\\u2019 EUROPEAN HEMATOLOGY ASSOCIATION | My\\u00e9lome Canada\",\"headline\":\"CONGR\\u00c8S ANNUEL 2019 DE L&rsquo; EUROPEAN HEMATOLOGY ASSOCIATION\",\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#articleImage\"},\"datePublished\":\"2019-06-18T00:00:00-05:00\",\"dateModified\":\"2025-08-19T08:28:21-05:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/#webpage\"},\"articleSection\":\"News &amp; Events, News &amp; Events, What's new at Myeloma Canada, What's new at Myeloma Canada, Facultatif, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"position\":2,\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/#listItem\",\"name\":\"Nouvelles de My\\u00e9lome Canada\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"name\":\"Accueil\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/#listItem\",\"position\":3,\"name\":\"Nouvelles de My\\u00e9lome Canada\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/#listItem\",\"name\":\"CONGR\\u00c8S ANNUEL 2019 DE L&rsquo; EUROPEAN HEMATOLOGY ASSOCIATION\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/#listItem\",\"position\":4,\"name\":\"CONGR\\u00c8S ANNUEL 2019 DE L&rsquo; EUROPEAN HEMATOLOGY ASSOCIATION\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/#listItem\",\"name\":\"Nouvelles de My\\u00e9lome Canada\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\",\"name\":\"Myeloma Canada\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"telephone\":\"+18887985771\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/\",\"name\":\"lemieuxbedard\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"lemieuxbedard\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/#webpage\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/\",\"name\":\"CONGR\\u00c8S ANNUEL 2019 DE L\\u2019 EUROPEAN HEMATOLOGY ASSOCIATION | My\\u00e9lome Canada\",\"description\":\"Nous revenons tout juste du congr\\u00e8s annuel 2019 de l\\u2019EHA (European Hematology Association ), au cours duquel la professeure Maria-Victoria Mateos (Universit\\u00e9 de Salamanque, Espagne) a discut\\u00e9 d\\u2019\\u00e9tudes remarquables sur le my\\u00e9lome multiple.Elle a pr\\u00e9sent\\u00e9 les r\\u00e9sultats prometteurs du premier volet de l\\u2019\\u00e9tude CASSIOPEIA portant sur l\\u2019ajout du daratumumab \\u00e0 la combinaison bort\\u00e9zomib-thalidomide-dexam\\u00e9thasone (D-VTd) comparativement \\u00e0\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2019\\\/06\\\/18\\\/congres-annuel-2019-de-l-european-hematology-association\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"datePublished\":\"2019-06-18T00:00:00-05:00\",\"dateModified\":\"2025-08-19T08:28:21-05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"name\":\"Myeloma Canada\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"CONGR\u00c8S ANNUEL 2019 DE L\u2019 EUROPEAN HEMATOLOGY ASSOCIATION | My\u00e9lome Canada","description":"Nous revenons tout juste du congr\u00e8s annuel 2019 de l\u2019EHA (European Hematology Association ), au cours duquel la professeure Maria-Victoria Mateos (Universit\u00e9 de Salamanque, Espagne) a discut\u00e9 d\u2019\u00e9tudes remarquables sur le my\u00e9lome multiple.Elle a pr\u00e9sent\u00e9 les r\u00e9sultats prometteurs du premier volet de l\u2019\u00e9tude CASSIOPEIA portant sur l\u2019ajout du daratumumab \u00e0 la combinaison bort\u00e9zomib-thalidomide-dexam\u00e9thasone (D-VTd) comparativement \u00e0","canonical_url":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/#blogposting","name":"CONGR\u00c8S ANNUEL 2019 DE L\u2019 EUROPEAN HEMATOLOGY ASSOCIATION | My\u00e9lome Canada","headline":"CONGR\u00c8S ANNUEL 2019 DE L&rsquo; EUROPEAN HEMATOLOGY ASSOCIATION","author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/#articleImage"},"datePublished":"2019-06-18T00:00:00-05:00","dateModified":"2025-08-19T08:28:21-05:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/#webpage"},"isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/#webpage"},"articleSection":"News &amp; Events, News &amp; Events, What's new at Myeloma Canada, What's new at Myeloma Canada, Facultatif, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","position":1,"name":"Accueil","item":"https:\/\/myeloma.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","name":"Actualit\u00e9s et \u00e9v\u00e9nement"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","position":2,"name":"Actualit\u00e9s et \u00e9v\u00e9nement","item":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/#listItem","name":"Nouvelles de My\u00e9lome Canada"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","name":"Accueil"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/#listItem","position":3,"name":"Nouvelles de My\u00e9lome Canada","item":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/#listItem","name":"CONGR\u00c8S ANNUEL 2019 DE L&rsquo; EUROPEAN HEMATOLOGY ASSOCIATION"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","name":"Actualit\u00e9s et \u00e9v\u00e9nement"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/#listItem","position":4,"name":"CONGR\u00c8S ANNUEL 2019 DE L&rsquo; EUROPEAN HEMATOLOGY ASSOCIATION","previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/#listItem","name":"Nouvelles de My\u00e9lome Canada"}}]},{"@type":"Organization","@id":"https:\/\/myeloma.ca\/fr\/#organization","name":"Myeloma Canada","url":"https:\/\/myeloma.ca\/fr\/","telephone":"+18887985771","logo":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/#organizationLogo"},"image":{"@id":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author","url":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/","name":"lemieuxbedard","image":{"@type":"ImageObject","@id":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g","width":96,"height":96,"caption":"lemieuxbedard"}},{"@type":"WebPage","@id":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/#webpage","url":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/","name":"CONGR\u00c8S ANNUEL 2019 DE L\u2019 EUROPEAN HEMATOLOGY ASSOCIATION | My\u00e9lome Canada","description":"Nous revenons tout juste du congr\u00e8s annuel 2019 de l\u2019EHA (European Hematology Association ), au cours duquel la professeure Maria-Victoria Mateos (Universit\u00e9 de Salamanque, Espagne) a discut\u00e9 d\u2019\u00e9tudes remarquables sur le my\u00e9lome multiple.Elle a pr\u00e9sent\u00e9 les r\u00e9sultats prometteurs du premier volet de l\u2019\u00e9tude CASSIOPEIA portant sur l\u2019ajout du daratumumab \u00e0 la combinaison bort\u00e9zomib-thalidomide-dexam\u00e9thasone (D-VTd) comparativement \u00e0","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/#breadcrumblist"},"author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"creator":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"datePublished":"2019-06-18T00:00:00-05:00","dateModified":"2025-08-19T08:28:21-05:00"},{"@type":"WebSite","@id":"https:\/\/myeloma.ca\/fr\/#website","url":"https:\/\/myeloma.ca\/fr\/","name":"Myeloma Canada","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"My\u00e9lome Canada |","og:type":"article","og:title":"CONGR\u00c8S ANNUEL 2019 DE L\u2019 EUROPEAN HEMATOLOGY ASSOCIATION | My\u00e9lome Canada","og:description":"Nous revenons tout juste du congr\u00e8s annuel 2019 de l\u2019EHA (European Hematology Association ), au cours duquel la professeure Maria-Victoria Mateos (Universit\u00e9 de Salamanque, Espagne) a discut\u00e9 d\u2019\u00e9tudes remarquables sur le my\u00e9lome multiple.Elle a pr\u00e9sent\u00e9 les r\u00e9sultats prometteurs du premier volet de l\u2019\u00e9tude CASSIOPEIA portant sur l\u2019ajout du daratumumab \u00e0 la combinaison bort\u00e9zomib-thalidomide-dexam\u00e9thasone (D-VTd) comparativement \u00e0","og:url":"https:\/\/myeloma.ca\/fr\/2019\/06\/18\/congres-annuel-2019-de-l-european-hematology-association\/","article:published_time":"2019-06-18T05:00:00+00:00","article:modified_time":"2025-08-19T13:28:21+00:00","twitter:card":"summary_large_image","twitter:title":"CONGR\u00c8S ANNUEL 2019 DE L\u2019 EUROPEAN HEMATOLOGY ASSOCIATION | My\u00e9lome Canada","twitter:description":"Nous revenons tout juste du congr\u00e8s annuel 2019 de l\u2019EHA (European Hematology Association ), au cours duquel la professeure Maria-Victoria Mateos (Universit\u00e9 de Salamanque, Espagne) a discut\u00e9 d\u2019\u00e9tudes remarquables sur le my\u00e9lome multiple.Elle a pr\u00e9sent\u00e9 les r\u00e9sultats prometteurs du premier volet de l\u2019\u00e9tude CASSIOPEIA portant sur l\u2019ajout du daratumumab \u00e0 la combinaison bort\u00e9zomib-thalidomide-dexam\u00e9thasone (D-VTd) comparativement \u00e0"},"aioseo_meta_data":{"post_id":"11252","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-09-18 17:06:47","updated":"2026-04-30 07:31:21","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=11252"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11252\/revisions"}],"predecessor-version":[{"id":31328,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11252\/revisions\/31328"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=11252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=11252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=11252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}